Abstract
In order to infect a host successfully, to access nutrients, and to promote the progression of disease, many pathogenic bacteria, such as the staphylococci and streptococci, produce exoproteins which enhance microbial virulence. Among these proteins is the family of toxins known today as the superantigens (SAg). This family includes the pyrogenic toxin SAg (PTSAg), such as the staphylococcal enterotoxins (SE, serotypes A-E, G, H), group A streptococcal pyrogenic exotoxins (SPE, serotypes A-C and possibly F), streptococcal SAg (SSA), and staphylococcal toxic shock syndrome toxin (TSST)-1. The following is a review of the biochemistry, structure, and mechanisms of pathogenicity of the PTSAg and the shared and unique properties of each. The properties of other relevant superantigenic proteins such as the staphylococcal exfoliative toxins (ETA, ETB) will also be discussed.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Altemeier WA, Lewis SA, Schlievert PM, Bergdoll MS, Bjornson HS, Staneck JL, Crass BA (1982) Staphylococcus aureus associated with toxic shock syndrome. Phage typing and toxin capability testing. Ann Intern Med 96:978–982
Bailey C, Smith T (1990) The reactive serine residue of epidermolytic toxin A. Biochem J 269:535–537
Bayles K, Iandolo J (1989) Genetic and molecular analyses of the gene encoding staphylococcal enterotoxin D. J Bacteriol 171:4799–4806
Bergdoll MS, Schlievert P (1984) Toxic-shock syndrome toxin. Lancet ii:691
Bergdoll MS, Crass BA, Reiser RF, Robbins RN, Davis JP (1981) A new staphylococcal enterotoxin, enterotoxin F, associated with toxic shock syndrome. Lancet i: 1017–1021
Berkley SF, Hightower AW, Broome CV, Reingold AL (1987) The relationship of tampon characteristics to menstrual toxic shock syndrome. JAMA 258:917–920
Blanco L, Choi EM, Connoly K, Thompson MR, Bonaventre PF (1990) Mutants of staphylococcal toxic shock syndrome toxin-1: mitogenicity and recognition by a neutralizing monoclonal antibody. Infect Immun 58:3020–3028
Blomster-Hautamaa D, Kreiswirth BN, Kornblum JS, Novick RP, Schlievert PM(1986) The nucleotide and partial amino acid sequence of toxic shock syndrome toxin-1. J Biol Chem 261:15783–15786
Bohach GA, Schlievert P (1987) Nucleotide sequence of the staphylococcal enterotoxin C1 gene and its relatedness to other pyrogenic exotoxins. Mol Gen Genet 209:15–20
Bohach GA, Schlievert P (1989) Conservation of the biologically active portions of staphylococcal enterotoxins C1 and C2. Infect Immun 57:2249–2252
Bohach GA, Fast DJ, Nelson RD, Schlievert PM (1990) Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol 17:251–272
Bonventre PF, Heeg H, Edwards CD III, Cullen CM (1995) A mutation at histidine residue 135 of toxic shock syndrome toxin yields an immunogenic protein with minimal toxicity. Infect Immun 63:509–515
Breiman RF, Davis JP, Facklam RR, Gray BM, Hoge CW, Kaplan EL, Mortimer EA, Schlievert PM, Schwartz B, Stevens DL, Todd JK (1993) Defining severe invasive streptococcal infections: rationale and consensus definition. JAMA 269:390–391
Callahan J, Herman A, Kappler J, Marrack P (1990) Stimulation of BIO.BR T-cells-with superantigenic staphylococcal toxins. J Immunol 144:2473–2479
Choi Y, Lafferty JA, Clements JR, Todd JK, Gelfand EW, Kappler J, Marrack P, Kotzin BL (1990) Selective expansion of T cells expressing Vβ2 in toxic shock syndrome. J Exp Med 172:981–984
Cone LA, Woodard DR, Schlievert PM, Tomay GS (1987)Clinical and bacteriologie observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N Engl J Med 317:146–149
Couch J, Soltis M, Betley M (1988) Cloning and nucleotide sequence of the type E staphylococcal enterotoxin gene. J Bacteriol 170:2954–2960
Davis JP, Chesney PJ, Wand PJ, La Venture M (1980) Investigation and laboratory team: toxic shock syndrome: epidemiologic features, recurrence, risk factors, and prevention. N Engl J Med 303:1429–1435
Deresiewicz RL, Woo J, Chan M, Finberg RW, Kasper DL (1994) Mutations affecting the activity of toxic shock syndrome toxin-1. Biochemistry 33:12844–12851
Fast DJ, Schlievert PM, Nelson RD (1989) Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production. Infect Immun 57:292–294
Fiume L, Stripe F (1966) Decreased RNA content in mouse liver nuclei after intoxication with α amanitin. Biochem Biophys Acta 123:643–645
Fleischer B, Bailey CJ (1992) Recombinant epidermolytic (exfoliative) toxin A of Staphylococcus aureus is not a superantigen. Med Microbiol Immunol 180:273–278
Fleischer B, Schrezenmeier H (1988) T-cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for MHC class II molecules on accessory or target cells. J Exp Med 167:1697–1708
Goshorn SC, Schlievert PM (1988) Nucleotide sequence of streptococcal pyrogenic exotoxin type C. Infect Immun 56:2518–2520
Harris T, Betley M (1995) Biological activities of staphylococcal enterotoxin type A mutants with N-terminal substitutions. Infect Immun 63:2133–2140
Harris TO, Grossman D, Kappler JW, Marrack P, Rich RR, Betley M J (1993) Lack of complete correlation between emetic and T-cell stimulatory activities of staphylococcal enterotoxins. Infect Immun 61:3175
Hauser AR, Schlievert P (1990) Nucleotide sequence of the streptococcal pyrogenic exotoxin type B gene and relationship between the toxin and streptococcal proteinase precursor. J Bacteriol 172:4536–4542
Hauser AR, Stevens DL, Kaplan EL, Schlievert PM (1991) Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome. J Clin Microbiol 29(8): 1562–1567
Hauser AR, Vath GM, Ohlendorf DH, Schlievert PM (1995) In: Thibodeau J, Sekaly R (eds) Bacterial superantigens: structure, function and therapeutic potential. Structural studies of streptococcal pyrogenic exotoxin superantigens. Landes, Austin, pp 39–48
Herman A, Kappler J, Marrack P, Pullen A (1991) Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu Rev Microbiol 9:745–772
Hoffmann ML, Jablonski LM, Crum KK, Hackett SP, Chi Y, Stauffacher CV, Stevens DL, Bohach GA (1994) Predictions of T-cell receptor and major histocompatibility complex-binding sites on staphylococcal enterotoxin C1. Infect Immun 62:3396–3407
Hovde C, Hackett S, Bohach G (1990) Nucleotide sequence of the staphylococcal enterotoxin C3 gene: sequence comparison of all three type C staphylococcal enterotoxins. Mol Gen Genet 220:329–333
Huang I, Hughes J, Bergdoll M (1987) Complete amino acid sequence of staphylococcal enterotoxin A. J Biol Chem 262:7006–7013
Hudson K, Robinson H, Fraser J (1993) Two adjacent residues in staphylococcal enterotoxins A and E determine T cell receptor Vb specificity. J Exp Med 177:175–184
Hurley JM, Shimonkevitz R, Hanagan A, Enney K, Boen E, Malmstrom S, Kotzin BL, Matsumura M (1995) Identification of class II major histocompatibility complex and T cell receptor binding sites in the superantigenic toxic shock syndrome toxin-1. J Exp Med 181:229–235
Jardetzky TS, Brown JH, Gorga JC, Stern LJ, Urban RG, Chi Y, Stauffacher C, Strominger JL, Wiley DC (1994) Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 368:711–718
Johnson DR, Stevens DL, Kaplan DL (1992) Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. J Infect Dis 166:374–382
Jones C, Khan S (1986) Nucleotide sequence of the enterotoxin B gene from Staphylococcus aureus. J Bacteriol 166:29–33
Kapral FA, Miller MM (1971) Product of Staphylococcus aureus responsible for the scalded-skin syndrome. Infect Immun 4:541–545
Keane WF, Gekker G, Schlievert PM, Peterson PK (1986) Enhancement of endotoxin-induced isolated renal tubular cell injury by toxic shock syndrome toxin-1. Am J Pathol 122:169–176
Kim YB, Watson DW (1970) A purified group A streptococcal pyrogenic exotoxin. Physicochemical and biological properties including the enhancement of susceptibility to endotoxin lethal shock. J Exp Med 131:611–628
Kim J, Urban RG, Strominger JL, Wiley DC (1994) Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1. Science 266:1870–1874
Kline JB, Collins CM (1996) Analysis of the superantigenic activity of mutant and allelic forms of streptococcal pyrogenic exotoxin A. Infect Immun 64:861–869
Kotzin BL, Leung DY, Kappler J, Marrack P (1993) Superantigens and their potential role in human disease. Adv Immunol 54:99–166
Lee CY, Schmidt JJ, Johnson-Winegar AD, Spero L, Iandolo J J (1987) Sequence determination and comparison of the exfoliative toxin A and toxin B genes from Staphylococcus aureus. J Bacteriol 169:3904–3909
Lee PK, Vercellotti GM, Deringer JR, Schlievert PM (1991a) Effects of staphylococcal toxic shock syndrome toxin-1 on aortic endothelial cells. J Infect Dis 164:711–719
Lee PK, Deringer JR, Kreiswirth BN, Novick RP, Schlievert PM (1991b) Fluid replacement protection of rabbits challenged subcutaneously with toxic shock syndrome toxins. Infect Immun 59:879–884
Leonard BA, Schlievert PM (1992) Immune cell lethality induced by streptococcal pyrogenic exotoxin A and endotoxin. Infect Immun 60:3747–3755
Lillibridge C, Melish M, Glasgow, L (1972) Site of action of exfoliative toxins in the staphylococcal scalded skin syndrome. Pediatrics 50:728–738
Marrack P, Kappler J (1990) The staphylococcal enterotoxins and their relatives. Science 248:705–711
McLay A, Arbuthnott J, Lyell A (1975) Action of staphylococcal epidermolytic toxin on mouse skin: an electron microscopic study. J Invest Dermatol 65:423–428
Melish ME, Glasgow LA (1970) The staphylococcal scalded-skin syndrome. The development of an experimental model. N Engl J Med 282:1114–1119
Morlock BA, Spero L, Johnson AD (1980) Mitogenic activity of staphylococcal exfoliative toxin. Infect Immun 30:381–384
Murray DL, Earhart CA, Mitchell DT, Ohlendorf DH, Novick RP, Schlievert PM (1996) Localization of biologically important regions on toxic shock syndrome toxin-1. Infect Immun 64:371–374
Musser JM, Hauser AR, Kim MH, Schlievert PM, Nelson K, Selander RK (1991) Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc Natl Acad Sci USA 88:2668–2672
Nishioka K, Katayama I, Sano S (1981) Possible binding of epidermolytic toxin to a subcellular fraction of the epidermis. J Dermatol 8:7–12
Norrby-Teglund A, Newton D, Kotb M, Holm SE, Norgren M (1994) Superantigenic properties of the group A streptococcal exotoxin speF (MF). Infect Immun 62:5227–5233
Osterholm M, Davis JP, Gibson RW, Mandel JS, Wintermeyer LA, Helms CM, Forfang JC, Rondeau J, Vergeront JM, and the Investigation Team (1982) Tri-state toxic shock syndrome study. I. Epidemiologic findings. J Infect Dis 145:431–440
Overington J (1992) Comparison of three-dimensional structures of homologous proteins. Curr Opin Struct Biol 2:394–401
Parsonnet J, Gillis ZA, Richter AG, Pier GB (1987) A rabbit model of toxic shock syndrome that uses a constant, subcutaneous infusion of toxic shock syndrome toxin-1. Infect Immun 55:1070–1076
Prévost G, Rifai S, Chaix ML, Piemont Y (1991) Functional evidence that the Ser-195 residue of staphylococcal exfoliative toxin A is essential for biological activity. Infect Immun 59:3337–3339
Recsei P, Krieswirth B, O’Reilly M, Schlievert PM, Gruss A, Novick RP (1986) Regulation of exoprptein gene expression by agr. Mol Gen Genet 202:58–61
Reda KB, Kapur V, Mollick JA, Lamphear JG, Musser JM, Rich RR (1994) Molecular characterization and phylogentic distribution of the streptococcal superantigen (ssa) from Streptococcus pyogenes. Infect Immun 62:1867–1874
Reingold AL, Hargrett NT, Dan BB, Shands KN, Strickland BY, Broome CV (1982) Nonmenstrual toxic shock syndrome: a review of 130 cases. Ann Intern Med 96:871–874
Ren K, Bannan JD, Pancholi V, Cheung AL, Robbins JC, Fischetti VA, Zabriskie JB (1994) Characterization and biological properties of a new staphylococcal exotoxin. J Exp Med 180:1675–1683
Roggiani M, Stoehr JA, Leonard BAB, Schlievert PM (1997) Analysis of toxicity of mutants of streptococcal pyrogenic exotoxin A. Infect Immun 65:2868–2875
Rogolsky M (1979) Nonenteric toxins of Staphylococcus aureus. Microbiol Rev 43:320–360
Schad EM, Zaitseva I, Zaitsev VN, Dohlsten M, Kalland T, Schlievert PM, Ohlendorf DH, Svensson LA (1995) Crystal structure of the superantigen staphylococcal exotoxin type A. EMBO J 14:3292–3301
Schlievert PM (1982)Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C. Infect Immun 36:123–128
Schlievert PM (1986) Staphylococcal enterotoxin B and toxic shock syndrome toxin-1 are significantly associated with nonmenstrual TSS. Lancet i:1149–1150
Schlievert PM (1993) Role of superantigens in human disease. J Infect Dis 167:997–1002
Schlievert PM, Blomster D (1983) Production of staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors. J Infect Dis 147:236–242
Schlievert PM, Watson DW (1978) Group A streptococcal pyrogenic exotoxin: pyrogenicity, alteration of blood-brain barrier, and separation of sites for pyrogenicity and enhancement of lethal endotoxin shock. Infect Immun 21:753–763
Schlievert PM, Bettin KM, Watson DW (1980) Inhibition of ribonucleic acid synthesis by group A streptococcal pyrogenic exotoxin. Infect Immun 27:542–548
Schlievert PM, Shands KN, Dan BB, Schmid GP, Nishimura RD (1981) Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic shock syndrome. J Infect Dis 143:509–516
Schlievert PM, Blomster DA, Kelly JA (1984) Toxic shock syndrome Staphylococcus aureus: effect of tampons on toxic shock syndrome toxin-1 production. Obstet Gynecol 64(5):666–671
Schlievert PM, Gocke JE, Deringer JR (1993) Group B streptococcal toxic shock like syndrome: report of a case and purification of an associated pyrogenic toxin. Clin Infect Dis 17:26–31
Schwab JH, Watson DW, Cromartie WJ (1953) Production of generalized Shwartzman reaction with group A streptococcal factors. Proc Soc Exp Biol Med 82:754–761
Schwab JH, Watson DW, Cromartie WJ (1955) Further studies of group A streptococcal factors with lethal and cardiotoxic properties. J Infect Dis 96:14–18
Schwab JH, Brown RR, Anderle SK, Schlievert PM (1993) Superantigen can reactivate bacterial cell wall-induced arthritis. J Immunol 150:4151–4159
Shands K, Schmid GP, Dan BB, Blum D, Guidotti RJ, Hargrett NT, Anderson RL, Hill DL, Broome CV, Band JD, Fraser DW (1980) Toxic shock syndrome in menstruating women: its association with tampon use and Staphylococcus aureus and the clinical features in 52 cases. N Engl J Med 303:1436–1442
Spero L, Metzger JF, Warren JR, Griffin BA (1975) Biological activity and complementation of two peptides of staphylococcal enterotoxin B formed by limited tryptic hydrolysis. J Biol Chem 250:5026
Stevens DL (1992) Invasive group A streptococcal infections. Clin Infect Dis 14:2–13
Stevens DL, Tanner MH, Winship J, Swarts R, Ries KM, Schlievert PM, Kaplan E (1989) Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 321:1–7
Sugiyama H, Hayama T (1965) Abdominal viscera as site of emetic action for staphylococcal enterotoxin in the monkey. J Infect Dis 115:330
Swaminathan S, Furey W, Pletcher J, Sax M (1992) Crystal structure of staphylococcal enterotoxin B, a superantigen. Nature 359:801–805
Todd J, Fishaut M, Kapral F, Welch T (1978) Toxic shock syndrome associated with phage group-I staphylococci. Lancet 2:1116–1118
Wagner G, Bohr L, Wagner P (1984) Tampon induced changes in vaginal oxygen carbon dioxide tensions. Am J Obstet Gynecol 148:147–150
Wagner JG, Schlievert PM, Assimacoupoulos AP, Stoehr JA, Carlson PJ, Komadina K (1997) Acute group G streptococcal myositis with toxic shock like syndrome. Clin Infect Dis (in press)
Watson DW (1959) Host-parasite factors in group A streptococcal infections. Pyrogenic and other effects on immunologic distinct exotoxins related to scarlet fever toxins. J Exp Med 111:255–283
Weeks CR, Ferretti JJ (1986) Nucleotide sequence of the type A Streptococcus pyogenes bacteriophage T12. Infect Immun 52:144–159
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Rago, J.V., Schlievert, P.M. (1998). Mechanisms of Pathogenesis of Staphylococcal and Streptococcal Superantigens. In: Vogt, P.K., Mahan, M.J. (eds) Bacterial Infection: Close Encounters at the Host Pathogen Interface. Current Topics in Microbiology and Immunology, vol 225. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80451-9_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-80451-9_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-80453-3
Online ISBN: 978-3-642-80451-9
eBook Packages: Springer Book Archive